BIRC5 and ovarian carcinoma: Similarly to 9F7-F11 activity, vitamin E analogues (α-tocopherol derivatives) inhibit the HER3-mediated AKT pro-survival pathway and the anti-apoptosis factors c-FLIP and survivin to favor caspase-mediated apoptosis in cisplatin-resistant ovarian cancer [51].